Abstract
AbstractHuman T‐cell leukemia virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurodegenerative disease characterized by selective loss of axons and myelin in the corticospinal tracts. This central axonopathy may originate from the impairment of anterograde axoplasmic transport. Previous work showed tau hyperphosphorylation at T181 in cerebrospinal fluid of HAM/TSP patients. Similar hyperphosphorylation occurs in SH‐SY5Y cells incubated with supernatant from MT‐2 cells (HTLV‐I‐infected lymphocytes secreting viral proteins, including Tax) that produce neurite shortening. Tau phosphorylation at T181 is attributable to glycogen synthase kinase 3‐β (GSK3‐β) and cyclin‐dependent kinase 5 (CDK5) activation. Here we investigate whether neurite retraction in the SH‐SY5Y model associates with concurrent changes in other tau hyperphosphorylable residues. Threonine 181 turned out to be the only tau hyperphosphorylated residue. We also evaluate the role of GSK3‐β and CDK5 in this process by using specific kinase inhibitors (LiCl, TDZD‐8, and roscovitine). Changes in both GSK3‐β active and inactive forms were followed by measuring the regulatory phosphorylable sites (S9 and Y216, inactivating and activating phosphorylation, respectively) together with changes in β‐catenin protein levels. Our results showed that LiCl and TDZD‐8 were unable to prevent MT‐2 supernatant‐mediated neurite retraction and also that neither Y216 nor S9 phosphorylations were changed in GSK3‐β. Thus, GSK3‐β seems not to play a role in T181 hyperphosphorylation. On the other hand, the CDK5 involvement in tau phosphorylation was confirmed by both the increase in its enzymatic activity and the absence of MT‐2 neurite retraction in the presence of roscovitine or CDK5 siRNA transfection. © 2011 Wiley‐Liss, Inc.
Bibliography
Maldonado, H., RamÃrez, E., Utreras, E., Pando, M. E., Kettlun, A. M., Chiong, M., Kulkarni, A. B., Collados, L., Puente, J., Cartier, L., & Valenzuela, M. A. (2011). Inhibition of cyclinâdependent kinase 5 but not of glycogen synthase kinase 3âβ prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human Tâcell leukemia virus type Iâinfected lymphocytes. Journal of Neuroscience Research, 89(9), 1489â1498. Portico.
Authors
11
- Horacio Maldonado (first)
- Eugenio Ramírez (additional)
- Elias Utreras (additional)
- María E. Pando (additional)
- Ana M. Kettlun (additional)
- Mario Chiong (additional)
- Ashok B. Kulkarni (additional)
- Lucía Collados (additional)
- Javier Puente (additional)
- Luis Cartier (additional)
- María A. Valenzuela (additional)
References
48
Referenced
22
10.1074/jbc.M409851200
10.1016/j.biopha.2007.02.005
10.1152/physrev.00024.2003
10.1073/pnas.190297597
/ Proc Natl Acad Sci U S A / Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase‐3β in cellular and animal models of neuronal degeneration by Bhat RV (2000)10.1186/1742-4690-5-76
10.1093/brain/awl269
10.1097/00005072-199704000-00009
10.4067/S0034-98872007000900007
10.1074/jbc.M206236200
10.1038/nrn1788
10.1016/S0166-2236(02)02255-5
10.1128/jvi.71.9.6982-6989.1997
/ J Virol / Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T‐cell lymphotropic virus type 1 Tax by Cowan EP (1997)10.1016/j.neuropharm.2008.09.012
10.3390/ijms10031045
10.1016/j.molmed.2004.07.001
10.1146/annurev.neuro.31.061307.090711
10.1007/s10571-007-9242-1
10.1046/j.1471-4159.2000.0750991.x
10.3389/neuro.02.002.2009
10.1016/j.brainres.2006.04.007
10.1158/1535-7163.MCT-08-0655
10.1016/S0301-0082(01)00011-9
10.1016/j.molmed.2009.01.003
10.1016/S1937-6448(08)00603-5
10.1016/j.neuroscience.2005.04.061
10.1007/s10571-009-9410-6
10.1074/jbc.M907757199
10.1074/jbc.M605178200
10.1111/j.1460-9568.2007.05955.x
10.1146/annurev.neuro.28.061604.135632
10.4067/S0716-97602008000300001
10.1007/s11481-010-9216-9
10.1074/jbc.M700610200
10.1373/clinchem.2004.039347
10.1016/S0140-6736(86)91298-5
10.1016/j.ymeth.2007.06.012
10.1016/S0168-1702(02)00276-9
10.1358/dof.2002.027.05.680587
10.1074/jbc.274.52.37046
10.1016/S1388-1981(02)00149-X
10.1007/PL00012495
10.1186/1743-8454-5-14
10.1016/j.mad.2008.12.006
10.1074/jbc.M211964200
10.1016/S0014-5793(98)00346-9
10.1016/j.dnarep.2004.11.006
10.1038/mt.2008.92
10.1016/S0896-6273(00)81200-3
Dates
Type | When |
---|---|
Created | 14 years, 2 months ago (June 10, 2011, 1:29 p.m.) |
Deposited | 1 year, 10 months ago (Oct. 16, 2023, 2:35 a.m.) |
Indexed | 1 month, 1 week ago (July 24, 2025, 7:41 a.m.) |
Issued | 14 years, 2 months ago (June 10, 2011) |
Published | 14 years, 2 months ago (June 10, 2011) |
Published Online | 14 years, 2 months ago (June 10, 2011) |
Published Print | 14 years ago (Sept. 1, 2011) |
@article{Maldonado_2011, title={Inhibition of cyclin‐dependent kinase 5 but not of glycogen synthase kinase 3‐β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T‐cell leukemia virus type I‐infected lymphocytes}, volume={89}, ISSN={1097-4547}, url={http://dx.doi.org/10.1002/jnr.22678}, DOI={10.1002/jnr.22678}, number={9}, journal={Journal of Neuroscience Research}, publisher={Wiley}, author={Maldonado, Horacio and Ramírez, Eugenio and Utreras, Elias and Pando, María E. and Kettlun, Ana M. and Chiong, Mario and Kulkarni, Ashok B. and Collados, Lucía and Puente, Javier and Cartier, Luis and Valenzuela, María A.}, year={2011}, month=jun, pages={1489–1498} }